The aim of the venture is to offer plant-based, sustainable and “highly effective alternatives” to the home and personal care markets.
“At present, there are few viable alternatives to palm and fossil sources that can be produced at scale to make those ingredients,” said Unilever, adding that the partnership with Geno marked its largest investment so far in developing biotechnology alternatives to palm oil.
Unilever’s chief R&D officer Richard Slater said that biotechnology has the potential to “revolutionize the sourcing of our cleansing ingredients and ensure that Unilever is a future-fit business.” Slater added that developing new materials will also help to make Unilever’s supply chains more resilient. “We will be marrying science and nature to make sure there is no trade-off for our consumers between the efficacy and sustainability of their products.”
In terms of timing, he said the plan is to run trials over the next few years, with the intention of scaling up production for use in products between 2026-28.“As we progress, we’d like to make this process even more sustainable by using the parts of crops that don’t currently make it into the supply chain — like the waste corn stubble that’s left in a field after a harvest. Lifecycle analysis shows that this is a lower carbon alternative.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Biden could lift some tariffs on China as he searches for solution to rising costsPresident Joe Biden is still debating whether to lift some tariffs on China put in place by his predecessor as he mines his authorities for ways to bring down skyrocketing prices that have caused his approval ratings to plummet.
Weiterlesen »
My Parents Bought Me a House. I Want to Charge My Boyfriend to Live With Me Anyway.Dear Pay Dirt: I don't know what the norm is.
Weiterlesen »
Gene Genies: Inside The Revolutionary Biotech That Can Edit DNA Inside Living HumansJohn Leonard built Intellia Therapeutics with Jennifer Doudna, the Nobel Prize-winning scientist who pioneered gene editing technology. Intellia has figured out how to alter disease-causing genes inside patients, but before any breakthrough treatments come, it must cure itself of financial ills.
Weiterlesen »
Movie Review: LightyearMOVIE REVIEW: Toy Story spin-off PixarsLightyear never achieves lift-off.
Weiterlesen »
Ankr Adds Ethereum's L2 Optimism to its Platform StackOne of Ethereum's most popular Layer 2 scaling solutions, Optimism, is now available for Ankr clients
Weiterlesen »
Warren proposes sweeping ban on location and health data salesThe bill aims to protect privacy in abortion access.
Weiterlesen »